Patient-Level Data for Drugs and Biological Products Submissions Containing Real-World Data and Real-World Evidence; Request for Information
The Food and Drug Administration (FDA or Agency), is announcing a request for information (RFI) from interested parties to share perspectives on patient-level data access related to the use of real-world evidence (RWE) in regulatory decision-making for drugs and biological product submissions. The purpose of this RFI is to solicit input from interested parties on innovative solutions to address the challenges in submitting patient-level data for real-world data (RWD) analyzed in clinical studies included in a marketing application. Interested parties may include regulated industry, health information technology (HIT) vendors, academic medical centers, electronic data capture vendors, patient advocates, and other interested parties.
- quotes — Patient-Level Data for Drugs and Biological Products Submissions Containing Real-World Data and Real-World Evidence; Request for Information (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/12/2026-22996/patient-level-data-for-drugs-and-biological-products-submissions-containing-real-world-data-and; status: unverified)
- quotes — summary: The Food and Drug Administration (FDA or Agency), is announcing a request for information (RFI) from interested parties to share perspectives on patient-level data access related to the use of real-world evidence (RWE) in regulatory decision-making for drugs and biological product submissions. The purpose of this RFI is to solicit input from interested parties on innovative solutions to address the challenges in submitting patient-level data for real-world data (RWD) analyzed in clinical studies included in a marketing application. Interested parties may include regulated industry, health information technology (HIT) vendors, academic medical centers, electronic data capture vendors, patient advocates, and other interested parties. (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/12/2026-22996/patient-level-data-for-drugs-and-biological-products-submissions-containing-real-world-data-and; status: unverified)
- quotes — url: https://www.federalregister.gov/documents/2026/11/12/2026-22996/patient-level-data-for-drugs-and-biological-products-submissions-containing-real-world-data-and (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/12/2026-22996/patient-level-data-for-drugs-and-biological-products-submissions-containing-real-world-data-and; status: unverified)
- quotes — source-subject: federal-register:2026-22996 (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/12/2026-22996/patient-level-data-for-drugs-and-biological-products-submissions-containing-real-world-data-and; status: unverified)
- quotes — source-edition: ni:///sha-256;nsA4wEZa6L8DteE8muqxSLWUUTOp8UzO3uNnGoukBRE (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/12/2026-22996/patient-level-data-for-drugs-and-biological-products-submissions-containing-real-world-data-and; status: unverified)
- quotes — source-metadata: {"subject":"federal-register:2026-22996","revision":"ni:///sha-256;nsA4wEZa6L8DteE8muqxSLWUUTOp8UzO3uNnGoukBRE","documentNumber":"2026-22996","documentUrl":"https://www.federalregister.gov/documents/2026/11/12/2026-22996/patient-level-data-for-drugs-and-biological-products-submissions-containing-real-world-data-and","title":"Patient-Level Data for Drugs and Biological Products Submissions Containing Real-World Data and Real-World Evidence; Request for Information","documentType":"Notice","publicationDate":"2026-11-12","publicationDatePrecision":"civil-day","agencies":["Food and Drug Administration","Health and Human Services Department"],"abstract":"The Food and Drug Administration (FDA or Agency), is announcing a request for information (RFI) from interested parties to share perspectives on patient-level data access related to the use of real-world evidence (RWE) in regulatory decision-making for drugs and biological product submissions. The purpose of this RFI is to solicit input from interested parties on innovative solutions to address the challenges in submitting patient-level data for real-world data (RWD) analyzed in clinical studies included in a marketing application. Interested parties may include regulated industry, health information technology (HIT) vendors, academic medical centers, electronic data capture vendors, patient advocates, and other interested parties.","commentsCloseOn":"2027-01-11","commentDeadlineFieldRequested":true,"effectiveOn":null,"sourceAction":"Notice; Request for Information.","federalRegisterCitation":"91 FR 72875","docketIds":["Docket No. FDA-2026-N- 10742"],"regulationIdNumbers":[],"cfrReferences":[],"correctionOf":null,"corrections":[],"source":{"originalApiUrl":"https://www.federalregister.gov/api/v1/documents.json?conditions%5Bpublication_date%5D%5Bgte%5D=2026-11-05&conditions%5Bpublication_date%5D%5Blte%5D=2026-11-12&per_page=100&page=1&order=newest&fields%5B%5D=document_number&fields%5B%5D=title&fields%5B%5D=type&fields%5B%5D=abstract&fields%5B%5D=html_url&fields%5B%5D=publication_date&fields%5B%5D=agencies&fields%5B%5D=comments_close_on&fields%5B%5D=effective_on&fields%5B%5D=action&fields%5B%5D=citation&fields%5B%5D=regulation_id_numbers&fields%5B%5D=cfr_references&fields%5B%5D=docket_ids&fields%5B%5D=correction_of&fields%5B%5D=corrections","originalResponseDigest":"sha256:e095feb5b9c8968c45f113720e63c822ba7fbb3afdfec0696bae46bdc204f9ef","originalResponseUri":"ni:///sha-256;4JX-tbnIloxF8RNyDmPIIrp_uzr9_sBpa65GvcIE-e8","normalizedLotDigest":"sha256:d3ff8e93b6fed45c9386d3c7086e789c7bc9c64bff674c189560c92a5daaf952","observedAt":"2026-11-12T21:30:47.088Z","provider":"https://www.federalregister.gov","publisher":{"name":"Office of the Federal Register","source":"https://www.federalregister.gov/reader-aids/developer-resources/rest-api","reproduction":"https://www.archives.gov/federal-register/faqs","officialNotice":"The source Federal Register edition, not this derived JSON, is authoritative. No government endorsement."},"evidenceClass":"source-dated government metadata, independently replayable from original HTTP bytes held by the source acquisition run"}} (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/12/2026-22996/patient-level-data-for-drugs-and-biological-products-submissions-containing-real-world-data-and; status: unverified)
- quotes — editorial-standing: source metadata; editorial acceptance pending (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/12/2026-22996/patient-level-data-for-drugs-and-biological-products-submissions-containing-real-world-data-and; status: unverified)